Is RCKT undervalued or overvalued?

As of 2025-03-17, the Intrinsic Value of Rocket Pharmaceuticals Inc (RCKT) is -12.13 USD. This RCKT valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.76 USD, the upside of Rocket Pharmaceuticals Inc is -238.50%. This means that RCKT is overvalued by 238.50%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

	Range	Selected	Upside
a
Fair Value	-12.13 - -12.13	-12.13	-238.50%
P/E	(24.02) - (55.91)	(38.70)	-541.8%
DDM - Stable	(34.25) - (570.21)	(302.23)	-3550.1%
DDM - Multi	(14.42) - (190.70)	(27.05)	-408.8%